SecBot SecBot
SECBOTREPLAY Home › Report › VOR

VOR · Vor Biopharma filed an S-3 registration statement to register 5,338,078…

Vor Biopharma Inc. · S-3 filed Apr 27, 2026 at 16:11 ET

At the news

NEUTRALIMPACT 3/10

S-3 filed Apr 27, 2026 at 16:11 ET

Vor Biopharma filed an S-3 registration statement to register 5,338,078 shares of common stock for resale by TCG Crossover Funds, issued in a March 2026 private placement at $14.05/share ($75M gross). The company will not receive any proceeds. This is a routine registration rights fulfillment and does not represent new equity issuance or capital raise.

  • Registers 5,338,078 shares for resale by selling stockholders (TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P.)
  • Shares were issued in a private placement on March 30, 2026 at $14.05 per share, gross proceeds ~$75M to the company
  • Company will not receive any proceeds from this resale offering
  • Stock closed at $13.81 on April 24, 2026; market cap ~$675M

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access